Acetaminophen Transfer Across the Placenta and the Assessment of Fetal Well-being | NCT01211912 | Trialant
CompletedInterventionalPhase 1Updated Sep 1, 2014
Acetaminophen Transfer Across the Placenta and the Assessment of Fetal Well-being
Acetaminophen Transfer Across the Placenta and the Assessment of Fetal Well-being
ClinicalTrials.gov ID
NCT01211912
Lead Sponsor
Mayo ClinicOTHER
Overall Status
Completed
Study Type
Interventional
Phase
Phase 1
Enrollment
56Actual
Last Update Posted
Sep 1, 2014Estimated
Start Date
Sep 2010
Primary Completion Date
Dec 2011Actual
Completion Date
Dec 2011Actual
Official Title
Acetaminophen Transfer Across the Placenta and the Assessment of Fetal Well-being
Brief Summary
This study has two aims:
to evaluate placental transfer of acetaminophen from mother to baby transplacentally given from 30 minutes to 24 hours prior to cesarean delivery (34 patients)
to understand the impact of maternal acetaminophen use on fetal movement and breathing (20 patients)